Pharmacelera raises €6M to expand in U.S. and build out its high speed, high accuracy, deep tech drug discovery platform
- Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital
- Financing will enable Pharmacelera to build ongoing relationships with major pharma and biotech customers in the US
- Pharmacelera’s platform scours vast chemical ‘exaSpace’ accurately for novel molecules
Barcelona, Spain, February 18, 2026 – Pharmacelera, a deep tech company applying Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery, has closed a €6 million investment round to accelerate its expansion in the United States and grow the capabilities of its proprietary platform.
